Tech Center 1600 • Art Units: 1654 1658 1676
This examiner grants 41% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18035267 | PEPTIDES FROM HUMAN B-CASEIN THAT HAVE ANTI-BACTERIAL ACTIVITY | Non-Final OA | The Regents of the University of California |
| 18303796 | SOLUBLE THY-1 COMPOSITIONS AND USE THEREOF TO TREAT OR REVERSE FIBROSIS | Non-Final OA | The Regents of the University of California |
| 18250406 | PEPTIDE TAG AND TAGGED PROTEIN CONTAINING SAME | Non-Final OA | IDEMITSU KOSAN CO.,LTD. |
| 18004104 | HUMAN RECOMBINANT ACE2-FC MUTANTS THAT DECOUPLE ANTI-SARS-COV-2 ACTIVITY FROM CARDIOVASCULAR EFFECTS | Non-Final OA | Northwestern University |
| 17288879 | SYNTHETIC PEPTIDES INDUCING IMMUNOGENIC CELL DEATH | Final Rejection | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE |
| 18041289 | PEPTIDES AND FORMULATIONS FOR CANCER TREATMENT | Non-Final OA | Peptinovo Biopharma, Inc. |
| 18449907 | IODINATED CROSSLINKED HYDROGELS AND METHODS OF FORMING THE SAME | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18492014 | INSECT NEUROPEPTIDES 7 | Non-Final OA | Solasta Bio Limited |
| 18246063 | POLYMERS AND NANOPARTICLE FORMULATIONS FOR SYSTEMIC NUCLEIC ACID DELIVERY | Non-Final OA | The Johns Hopkins University |
| 17628142 | SEPARATED PEPTIDE | Non-Final OA | National University Corporation Tokai National Higher Education and Research System |
| 17418305 | METHOD FOR STABILIZING BIOACTIVITY OF GROWTH FACTOR | Final Rejection | National Cheng Kung University |
| 18717568 | PEPTIDES AND COMPOSITIONS FOR USE IN COSMETICS | Final Rejection | LIPOTRUE, S.L. |
| 18248240 | NOVEL PEPTOIDS AND USE THEREOF FOR PREVENTING OR TREATING CHRONIC PAIN | Non-Final OA | Université de Montpellier |
| 18002478 | LONG ACTING GLP-1/GIP DUAL AGONISTS | Non-Final OA | SUN PHARMACEUTICAL INDUSTRIES LIMITED |
| 18620789 | METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Final Rejection | Stealth BioTherapeutics Inc. |
| 18460346 | METHODS AND COMPOSITIONS FOR TREATING, PREVENTING, INHIBITING, AMELIORATING OR DELAYING THE ONSET OF OPHTHALMIC CONDITIONS | Non-Final OA | Stealth BioTherapeutics Inc. |
| 18131280 | PEPTIDIC OLIGOMERS AND METHODS OF USING THE SAME | Non-Final OA | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS |
| 18037287 | PROTEIN HYDROGELS AND METHODS FOR THEIR PREPARATION | Non-Final OA | THE UNIVERSITY OF BRITISH COLUMBIA |
| 17935255 | METHODS FOR TREATING LIVER DISEASE | Non-Final OA | SORBONNE UNIVERSITÉ |
| 17928759 | EFFICIENT PEPTIDE CONDENSATION METHOD FOR DIFFICULT SEQUENCES | Non-Final OA | Chugai Seiyaku Kabushiki Kaisha |
| 18534263 | MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF | Final Rejection | CytomX Therapeutics, Inc. |
| 18097077 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | Final Rejection | Protagonist Therapeutics, Inc. |
| 16104037 | Composition and Method for Therapeutic Agent Delivery During Pregnancy | Non-Final OA | University of Mississippi Medical Center |
| 15694592 | MOLECULAR SENSORS | Final Rejection | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN |
| 17629313 | PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF | Final Rejection | CAREGEN CO., LTD. |
| 18041729 | ANNEXIN A1 N-TERMINAL PEPTIDE FORMULATIONS AND METHODS | Non-Final OA | ResoTher Pharma A/S |
| 17455880 | NERVE GROWTH FACTOR MUTANT | Final Rejection | Staidson (Beijing) Biopharmaceuticals Co., Ltd. |
| 17996875 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER | Final Rejection | L-BASE CO., LTD. |
| 17918930 | NOVEL ALPHA-HELICAL DOUBLE-SIDED CELL PENETRATING PEPTIDE AND USE THEREOF | Final Rejection | CAMP THERAPEUTICS INC. |
| 17995092 | NOVEL ANTIBACTERIAL PEPTIDE AND USE THEREOF | Final Rejection | ANYGEN CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy